ImmunoVaccine Technologies Inc. (IVT) (IMV) Announces 2010 Third Quarter Results
11/29/2010 11:15:59 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) (IMV) Announces the Departure of Its Chief Financial Officer
6/8/2010 10:05:08 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) (IMV) Revises Escrow Securities Schedule
10/23/2009 10:02:29 AM
More...
|
Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol
10/5/2009 10:39:45 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Appoints New CFO
9/28/2009 10:15:55 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Partners With Scancell to Advance DNA Vaccine Delivery
8/6/2009 9:16:11 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Licenses Immunotope, Inc.'s Breast, Ovarian and Prostate Cancer Antigens
7/15/2009 10:22:27 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Partners with FIT Biotech to Advance a Therapeutic HIV Vaccine
5/27/2009 9:00:31 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats
4/14/2009 11:09:45 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Signs Agreement with La Jolla Institute for Allergy and Immunology to Test the Application of DepoVax(TM) Technology to Battle Influenza
3/27/2009 8:45:42 AM
More...
|
|